Innovation

The lungs are one of most permeable ports of the human body facilitating a fast and clean compound uptake into the bloodstream. Therefore, pulmonary drug delivery is a highly efficient way for compound administration.

Despite the huge potential of pulmonary drug delivery and the increasing market of inhalable therapies limited research results are provided due to the lack of accurate models.

Alexis enables new opportunities by combining:

Together with our partners we investigate and develop new class of health-enabling lipid-carriers and inhalable supplements for a facilitated and safe compound uptake.